查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
药物发现服务市场：趋势、机遇、竞争分析 [2023-2028]
市场调查报告书
商品编码
1285024

药物发现服务市场：趋势、机遇、竞争分析 [2023-2028]

Drug Discovery Services Market: Trends, Opportunities and Competitive Analysis [2023-2028]
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

药物发现服务市场趋势与预测

到 2028 年，全球药物发现服务市场预计将达到 373 亿美元，2023 年至 2028 年的复合年增长率为 14.1%。 该市场的主要驱动力是由于各种疾病病例数量的增加而导致对药物发现服务的需求不断增加、最终用户对专业测试服务的需求不断增加以及对不明药物的研究活动不断增加。 在未来的全球药物发现服务市场中，我们可以期待製药和生物技术公司以及学术机构市场的商机。

药物发现服务公司名单

市场上的公司根据其提供的产品质量进行竞争。 该市场的主要参与者专注于扩大製造设施、投资研发、升级基础设施以及利用整个价值链的整合机会。 这些策略使药物发现服务公司能够满足不断增长的需求、确保竞争优势、开发创新产品和技术、降低製造成本并扩大客户群。

药物发现服务市场洞察

  • Lucintel 预计，由于小分子外包项目的增加以及学术机构、生物技术公司和大型製药公司越来越多地采用，化学服务将在预测期内成为最大的细分市场。我预计这一趋势将维持不变。
  • 此外，由于老年人慢性病的增加以及製药和生物製药公司对新药开发的兴趣日益浓厚，预计製药公司和生物技术公司将继续成为最大的细分市场。
  • 由于製药公司和生物企业对研发活动的积极投资、使用先进设施进行持续的药物发现研究以及主要 CRO 的存在，北美地区在预测期内将继续增长。预计将成为最大的地区。

本报告回答了 11 个关键问题：

  • Q.1.您的细分市场中最有前途和高增长的机会是什么？
  • Q.2.哪些领域将以更快的速度增长？为什么？
  • Q.3.您认为哪些地区的增长速度会更快？为什么？
  • Q.4.影响市场动态的关键因素有哪些？ 这个市场的主要挑战和商业风险是什么？
  • Q.5.这个市场的业务风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.这个市场中的客户需求有哪些变化？
  • Q.8.市场有哪些新发展？ 哪些公司正在引领这些发展？
  • Q.9.这个市场的主要参与者是谁？ 主要参与者采取哪些战略举措来发展业务？
  • Q.10.该市场上的竞争产品有哪些？因材料或产品替代而导致市场份额损失的威胁是什么？
  • 问题 11.过去五年发生了哪些併购以及它们对行业产生了哪些影响？

内容

第 1 章执行摘要

第 2 章全球药物发现服务市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 行业驱动因素和挑战

第三章2017-2028年市场趋势及预测分析

  • 宏观经济趋势（2017-2022 年）和预测（2023-2028 年）
  • 全球药物发现服务市场趋势（2017-2022 年）和预测（2023-2028 年）
  • 按流程划分的全球药物发现服务市场
    • 目标选择
    • 目标验证
    • H2L 的识别
    • 阅读优化
    • 候选人验证
  • 按类型划分的全球药物发现服务市场
    • 化学服务
    • 生物服务
  • 按药物类型划分的全球药物发现服务市场
    • 小分子药物
    • 生物製药
  • 按治疗领域划分的全球药物发现服务市场
    • 肿瘤
    • 神经病学
    • 心血管疾病
    • 呼吸系统疾病
    • 糖尿病和其他治疗领域
  • 按最终用户划分的全球药物发现服务市场
    • 製药和生物技术公司
    • 学术机构
    • 其他

第四章2017-2028年分地区市场趋势及预测分析

  • 按地区划分的药物发现服务市场
  • 北美的药物发现服务市场
  • 欧洲药物发现服务市场
  • 亚太药物发现服务市场
  • 其他区域药物发现服务市场

第五章竞争分析

  • 产品组合分析
  • 业务整合
  • 波特五力分析

第 6 章增长机会和战略分析

  • 增长机会分析
    • 按流程划分的全球药物发现服务市场增长机会
    • 按类型划分的全球药物发现服务市场增长机会
    • 按药物类型划分的全球药物发现服务市场增长机会
    • 按治疗领域划分的全球药物发现服务市场的增长机会
    • 最终用户的全球药物发现服务市场增长机会
    • 按地区划分的全球药物发现服务市场增长机会
  • 全球药物发现服务市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球药物发现服务市场的容量
    • 全球药物发现服务市场的合併、收购和合资企业
    • 身份验证和许可

第 7 章主要公司简介

  • Eurofins Scientific
  • Evotec SE
  • Charles River Laboratories International
  • GenScript
  • Thermo Fisher Scientific
  • Oncodesign Services
  • ChemPartner Co.
  • DiscoverX Corp.
  • QIAGEN
  • Domainex Ltd
简介目录

Drug Discovery Services Market Trends and Forecast

The future of the global drug discovery services market looks promising with opportunities in the pharmaceutical & biotechnology companies and academic institute markets. The global drug discovery services market is expected to reach an estimated $37.3 billion by 2028 with a CAGR of 14.1% from 2023 to 2028. The major drivers for this market are increasing need for drug discovery services with growing cases of various diseases, growing demand for specialized testing services among end users, and rising research activity on unidentified drugs.

A more than 150-page report is developed to help in your business decisions.

Drug Discovery Services Market by Segment

The study includes a forecast for the global drug discovery services market by process, type, drug type, therapeutic area, end users, and region, as follows:

Drug Discovery Services Market by Process [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Target Selection
  • Target Validation
  • Hit-to-Lead Identification
  • Lead Optimization
  • Candidate Validation

Drug Discovery Services Market by Type [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Chemistry Services
  • Biology Services

Drug Discovery Services Market by Drug Type [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Small-molecule Drugs
  • Biologics

Drug Discovery Services Market by Therapeutic Area [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Oncology
  • Neurology
  • Cardiovascular Diseases
  • Respiratory Diseases
  • Diabetes and Other Therapeutic Areas

Drug Discovery Services Market by End Users [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Pharmaceutical & Biotechnology Companies
  • Academic Institutes
  • Others

Drug Discovery Services Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Drug Discovery Services Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies drug discovery services companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the drug discovery services companies profiled in this report include.

  • Eurofins Scientific
  • Evotec SE
  • Charles River Laboratories International
  • GenScript
  • Thermo Fisher Scientific
  • Oncodesign Services
  • ChemPartner Co.
  • DiscoverX Corp.
  • QIAGEN
  • Domainex Ltd

Drug Discovery Services Market Insights

  • Lucintel forecasts that chemistry services will remain the largest segment over the forecast period due to growing number of outsourcing projects for small molecules and increasing adoption in academics, biotechnology companies, and large pharmaceutical companies.
  • Within this market, pharmaceutical & biotechnology companies is expected to remain the largest segment due to surge in the number of chronic diseases among the elderly population and growing interest of pharmaceutical and biopharmaceutical companies in developing new drugs.
  • North America is expected to remain the largest region during the forecast period due to supportive financial investment in the R&D activities by pharmaceutical and biopharmaceutical companies, availability of advanced equipment for continuous drug discovery research, and presence of key CROs in the region.

Features of the Drug Discovery Services Market

  • Market Size Estimates: Drug discovery services market size estimation in terms of value ($B)
  • Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
  • Segmentation Analysis: Drug discovery services market size by various segments, such as by process, type, drug type, therapeutic area, end users, and region
  • Regional Analysis: Drug discovery services market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different by process, type, drug type, therapeutic area, end users, and regions for the drug discovery services market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape for the drug discovery services market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the drug discovery services market size?

Answer: The global drug discovery services market is expected to reach an estimated $37.3 billion by 2028.

Q2. What is the growth forecast for drug discovery services market?

Answer: The global drug discovery services market is expected to grow with a CAGR of 14.1% from 2023 to 2028.

Q3. What are the major drivers influencing the growth of the drug discovery services market?

Answer: The major drivers for this market are increasing need for drug discovery services with augmenting cases of various diseases, growing demand for specialized testing services among end users, and rising research activity on unidentified drugs.

Q4. What are the major segments for drug discovery services market?

Answer: The future of the drug discovery services market looks promising with opportunities in the pharmaceutical & biotechnology companies and academic institute markets.

Q5. Who are the key drug discovery services companies?

Answer: Some of the key drug discovery services companies are as follows:

  • Eurofins Scientific
  • Evotec SE
  • Charles River Laboratories International
  • GenScript
  • Thermo Fisher Scientific
  • Oncodesign Services
  • ChemPartner Co.
  • DiscoverX Corp.
  • QIAGEN
  • Domainex Ltd

Q6. Which drug discovery services segment will be the largest in future?

Answer:Lucintel forecasts that chemistry services will remain the largest segment over the forecast period due to growing number of outsourcing projects for small molecules and increasing adoption in academics, biotechnology companies, and large pharmaceutical companies.

Q7. In drug discovery services market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to remain the largest region during the forecast period due to supportive financial investment in the R&D activities by pharmaceutical and biopharmaceutical companies, availability of advanced equipment for continuous drug discovery research, and presence of key CROs in the region.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

  • Q.1.What are some of the most promising, high-growth opportunities for the drug discovery services market by process (target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation), type (chemistry services and biology services), drug type (small-molecule drugs and biologics), therapeutic area (oncology, neurology, cardiovascular diseases, respiratory diseases, and diabetes and other therapeutic areas), end users (pharmaceutical & biotechnology companies, academic institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity did occur in the last five years and how did they impact the industry?

Table of Contents

1. Executive Summary

2. Global Drug Discovery Services Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Global Drug Discovery Services Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global Drug Discovery Services Market by Process
    • 3.3.1: Target Selection
    • 3.3.2: Target Validation
    • 3.3.3: Hit-to-Lead Identification
    • 3.3.4: Lead Optimization
    • 3.3.5: Candidate Validation
  • 3.4: Global Drug Discovery Services Market by Type
    • 3.4.1: Chemistry Services
    • 3.4.2: Biology Services
  • 3.5: Global Drug Discovery Services Market by Drug Type
    • 3.5.1: Small-molecule Drugs
    • 3.5.2: Biologics
  • 3.6: Global Drug Discovery Services Market by Therapeutic Area
    • 3.6.1: Oncology
    • 3.6.2: Neurology
    • 3.6.3: Cardiovascular Diseases
    • 3.6.4: Respiratory Diseases
    • 3.6.5: Diabetes and Other Therapeutic Areas
  • 3.7: Global Drug Discovery Services Market by End Users
    • 3.7.1: Pharmaceutical & Biotechnology Companies
    • 3.7.2: Academic Institutes
    • 3.7.3: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Drug Discovery Services Market by Region
  • 4.2: North American Drug Discovery Services Market
    • 4.2.1: North American Drug Discovery Services Market by Type: Chemistry Services and Biology Services
    • 4.2.2: North American Drug Discovery Services Market by End Users: Pharmaceutical & Biotechnology Companies, Academic Institutes, and Others
  • 4.3: European Drug Discovery Services Market
    • 4.3.1: European Drug Discovery Services Market by Type: Chemistry Services and Biology Services
    • 4.3.2: European Drug Discovery Services Market by End Users: Pharmaceutical & Biotechnology Companies, Academic Institutes, and Others
  • 4.4: APAC Drug Discovery Services Market
    • 4.4.1: APAC Drug Discovery Services Market by Type: Chemistry Services and Biology Services
    • 4.4.2: APAC Drug Discovery Services Market by End Users: Pharmaceutical & Biotechnology Companies, Academic Institutes, and Others
  • 4.5: ROW Drug Discovery Services Market
    • 4.5.1: ROW Drug Discovery Services Market by Type: Chemistry Services and Biology Services
    • 4.5.2: ROW Drug Discovery Services Market by End Users: Pharmaceutical & Biotechnology Companies, Academic Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Drug Discovery Services Market by Process
    • 6.1.2: Growth Opportunities for the Global Drug Discovery Services Market by Type
    • 6.1.3: Growth Opportunities for the Global Drug Discovery Services Market by Drug Type
    • 6.1.4: Growth Opportunities for the Global Drug Discovery Services Market by Therapeutic Area
    • 6.1.5: Growth Opportunities for the Global Drug Discovery Services Market by End Users
    • 6.1.6: Growth Opportunities for the Global Drug Discovery Services Market by Region
  • 6.2: Emerging Trends in the Global Drug Discovery Services Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Drug Discovery Services Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Drug Discovery Services Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Eurofins Scientific
  • 7.2: Evotec SE
  • 7.3: Charles River Laboratories International
  • 7.4: GenScript
  • 7.5: Thermo Fisher Scientific
  • 7.6: Oncodesign Services
  • 7.7: ChemPartner Co.
  • 7.8: DiscoverX Corp.
  • 7.9: QIAGEN
  • 7.10: Domainex Ltd